Novartis reclaims tk technology.
Johnson
E
E
D001932:Brain Neoplasms / Q000628:therapy; D002986:Clinical Trials as Topic; D005260:Female; D015316:Genetic Therapy; D005822:Genetic Vectors; D005909:Glioblastoma / Q000628:therapy; D006801:Humans; D010051:Ovarian Neoplasms / Q000628:therapy; D012190:Retroviridae / Q000235:genetics; D013937:Thymidine Kinase / Q000235:genetics*; D014481:United States
D013937:Thymidine Kinase